Pharming Group NV (PHARMa)

1.122
+0.365(+48.31%)
  • Volume:
    1,560,773
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.097 - 1.146
Unusual trading volume
1 / 2

PHARMa Overview

Prev. Close
0.757
Day's Range
1.097-1.146
Revenue
202.4M
Open
1.131
52 wk Range
0.661-1.146
EPS
0.032
Volume
1,560,773
Market Cap
746.36M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
529,968
P/E Ratio
33.73
Beta
1.39
1-Year Change
25.98%
Shares Outstanding
652,413,892
Next Earnings Date
-
What is your sentiment on Pharming Group?
or
Market is currently closed. Voting is open during market hours.

Pharming Group NV Analysis

  • Barclays CEO Resigns
    • ByTrade The News-

    Ireland Set To Sell Bills In Return For Markets Since Entering Bailout ConditionsEconomic Data(EU) ECB: €303M borrowed in overnight loan facility (lowest level since late...

Pharming Group NV Company Profile

Pharming Group NV Company Profile

Employees
262

Pharming Group NV is a biopharmaceutical company based in the Netherlands. The Company is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The Company's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • Consolideerd een beetje op het moment.
    0
    • 0.85
      0
      • Prepare for very good news, coming before the end off Q3.cheers to Pharming
        0
        • Oh dear....not the best Q2 results, but expected. Diluted EPS hasn't changed. Outlook is OK I think.
          0
          • financial results tomorrow 💪
            0
            • I’m sorry to say but this Dutch company is probably the worst stock in Holland, where it fell from 227 € to only twenty cents.
              3
              • America is waking up! Pharming is the best Healtcare / Biothechnology stock to buy in 2021! The future of this company is very good. It's up to you! Cheers to day!
                1
                • Here we go
                  0
                  • patent pending in the US. NICE 1
                    0
                    • what happen to their COVID vaccine?
                      0
                      • never had a vaccin. ruconest cured people after theyhad complications due to covid
                        0
                      • A dead bird. Waiting 4 martch before closing the door for ever.
                        0
                      • 0